Pfizer Inc. (PFE)
After hours:
| Previous Close | 29.34 |
| Open | 29.36 |
| Bid | 29.12 x 4000 |
| Ask | 29.10 x 2200 |
| Day's Range | 28.95 - 29.44 |
| 52 Week Range | 25.20 - 33.92 |
| Volume | |
| Avg. Volume | 31,953,589 |
| Market Cap | 166.261B |
| Beta (5Y Monthly) | 0.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.46 |
| Earnings Date | Oct 29, 2024 |
| Forward Dividend & Yield | 1.68 (5.76%) |
| Ex-Dividend Date | Nov 08, 2024 |
| 1y Target Est | 33.34 |
Investor's Business DailyNovavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back.
Business WireU.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors
NEW YORK, October 11, 2024--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 12 years of age and older with hemophilia A (congenital factor VIII deficiency) without factor VIII (FVIII) inhibitors, or hemophilia B (congenital factor IX deficiency) without factor IX (FIX) inhibitors.
Investor's Business DailyIs Pfizer Stock A Sell Following The First Salvo In Its Battle With Starboard?
Is Pfizer stock a sell after activist investor Starboard Value reportedly took a $1 billion stake in the drugmaker? Is PFE stock a sell?
